Fidelity Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.85M | Buy |
11,674
+1,876
| +19% | +$254K | ﹤0.01% | 2781 |
|
|
2026
Q1 | $1.25M | Buy |
9,798
+1,326
| +16% | +$166K | ﹤0.01% | 2796 |
|
|
2025
Q4 | $1.04M | Buy |
8,472
+1,888
| +29% | +$216K | ﹤0.01% | 2838 |
|
|
2025
Q3 | $660K | Buy |
6,584
+870
| +15% | +$78.4K | ﹤0.01% | 2941 |
|
|
2025
Q2 | $474K | Sell |
5,714
-1,066
| -16% | -$85K | ﹤0.01% | 2975 |
|
|
2025
Q1 | $550K | Buy |
6,780
+99
| +1% | +$8.85K | ﹤0.01% | 2866 |
|
|
2024
Q4 | $602K | Sell |
6,681
-259
| -4% | -$25.1K | ﹤0.01% | 2851 |
|
|
2024
Q3 | $686K | Buy |
6,940
+830
| +14% | +$81.5K | ﹤0.01% | 2740 |
|
|
2024
Q2 | $566K | Buy |
6,110
+1,203
| +25% | +$108K | ﹤0.01% | 2691 |
|
|
2024
Q1 | $467K | Sell |
4,907
-250
| -5% | -$23.2K | ﹤0.01% | 2744 |
|
|
2023
Q4 | $462K | Buy |
5,157
+759
| +17% | +$56.4K | ﹤0.01% | 2704 |
|
|
2023
Q3 | $321K | Sell |
4,398
-830
| -16% | -$66.3K | ﹤0.01% | 2748 |
|
|
2023
Q2 | $435K | Buy |
5,228
+1,887
| +56% | +$158K | ﹤0.01% | 2696 |
|
|
2023
Q1 | $255K | Sell |
3,341
-1,892
| -36% | -$157K | ﹤0.01% | 2899 |
|
|
2022
Q4 | $434K | Buy |
5,233
+65
| +1% | +$5.26K | ﹤0.01% | 2759 |
|
|
2022
Q3 | $410K | Buy |
5,168
+1,698
| +49% | +$143K | ﹤0.01% | 2841 |
|
|
2022
Q2 | $258K | Sell |
3,470
-1,370
| -28% | -$103K | ﹤0.01% | 3061 |
|
|
2022
Q1 | $434K | Sell |
4,840
-51,776
| -91% | -$4.78M | ﹤0.01% | 3029 |
|
|
2021
Q4 | $6.34M | Sell |
56,616
-7,336
| -11% | -$885K | ﹤0.01% | 2285 |
|
|
2021
Q3 | $8.04M | Sell |
63,952
-87,839
| -58% | -$11.3M | ﹤0.01% | 2199 |
|
|
2021
Q2 | $20.6M | Sell |
151,791
-12,181
| -7% | -$1.6M | ﹤0.01% | 1841 |
|
|
2021
Q1 | $22.2M | Buy |
163,972
+451
| +0.3% | +$67.5K | ﹤0.01% | 1757 |
|
|
2020
Q4 | $23M | Sell |
163,521
-1,233
| -0.7% | -$158K | ﹤0.01% | 1658 |
|
|
2020
Q3 | $18.4M | Buy |
164,754
+981
| +0.6% | +$110K | ﹤0.01% | 1599 |
|
|
2020
Q2 | $18.3M | Buy |
163,773
+14,377
| +10% | +$1.42M | ﹤0.01% | 1588 |
|
|
2020
Q1 | $11.6M | Buy |
149,396
+23,172
| +18% | +$2.05M | ﹤0.01% | 1648 |
|
|
2019
Q4 | $12M | Buy |
126,224
+6,769
| +6% | +$586K | ﹤0.01% | 1787 |
|
|
2019
Q3 | $9.11M | Buy |
119,455
+16,165
| +16% | +$1.34M | ﹤0.01% | 1869 |
|
|
2019
Q2 | $9.06M | Buy |
103,290
+47,414
| +85% | +$4.04M | ﹤0.01% | 1920 |
|
|
2019
Q1 | $5.06M | Buy |
55,876
+20,363
| +57% | +$1.73M | ﹤0.01% | 2077 |
|
|
2018
Q4 | $2.55M | Sell |
35,513
-5,454
| -13% | -$439K | ﹤0.01% | 2228 |
|
|
2018
Q3 | $3.93M | Buy |
40,967
+975
| +2% | +$94.5K | ﹤0.01% | 2226 |
|
|
2018
Q2 | $3.81M | Buy |
39,992
+8,273
| +26% | +$760K | ﹤0.01% | 2214 |
|
|
2018
Q1 | $2.78M | Buy |
31,719
+6,810
| +27% | +$622K | ﹤0.01% | 2311 |
|
|
2017
Q4 | $2.11M | Sell |
24,909
-148,333
| -86% | -$12.4M | ﹤0.01% | 2348 |
|
|
2017
Q3 | $15M | Sell |
173,242
-18,460
| -10% | -$1.48M | ﹤0.01% | 1793 |
|
|
2017
Q2 | $14.8M | Buy |
191,702
+11,241
| +6% | +$797K | ﹤0.01% | 1798 |
|
|
2017
Q1 | $12.5M | Buy |
180,461
+66,463
| +58% | +$4.46M | ﹤0.01% | 1883 |
|
|
2016
Q4 | $6.75M | Buy |
+113,998
| New | +$7.04M | ﹤0.01% | 2099 |
|
|
2013
Q4 | – | Sell |
-283,428
| Closed | -$12.2M | – | 2701 |
|
|
2013
Q3 | $12.2M | Buy |
283,428
+212,028
| +297% | +$8.59M | ﹤0.01% | 1888 |
|
|
2013
Q2 | $2.48M | Buy |
+71,400
| New | +$2.51M | ﹤0.01% | 2284 |
|
Other funds holding XBI
JFG
Fidelity Investments's XBI Position: Q2 2026 in Review
Fidelity Investments increased its State Street SPDR S&P Biotech ETF (XBI) stake by 19% in Q2 2026, buying an estimated $254K and bringing the position to 11,674 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2781.
Fidelity Investments first reported a position in XBI in Q2 2013 and has held it in 41 quarters since. The position peaked at $23M in Q4 2020. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Fidelity Investments held 11,674 shares of State Street SPDR S&P Biotech ETF worth $1.85M as of Q2 2026.
- Fidelity Investments bought 1,876 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $254K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2781 holding.
- Fidelity Investments first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 41 quarters since.
- Fidelity Investments's State Street SPDR S&P Biotech ETF position peaked at $23M in Q4 2020.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.